Related Experiment Videos
Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic
J Beaudreuil1, G Mbalaviele, M Cohen-Solal
1Inserm Unité 349, Cell and Molecular Biology of Bone and Cartilage, Centre Viggo Petersen, Hôpital Lariboisière, Paris, France.
Summary
Transforming growth factor-beta 1 (TGF-beta 1) reduces bone loss in ovariectomized rats by inhibiting osteoclast activity. This study investigated TGF-beta 1
Area of Science:
- Bone Biology
- Endocrinology
- Osteoporosis Research
Background:
- Estrogen deficiency in rats leads to increased osteoclastic resorption and rapid bone loss.
- Transforming growth factor-beta (TGF-beta) is secreted by osteoblastic cells in response to 17 beta-estradiol.
- In vivo effects of TGF-beta on bone resorption remain largely unknown.
Purpose of the Study:
- To investigate the short-term effects of TGF-beta 1 on bone resorption in ovariectomized rats.
Main Methods:
- Ovariectomized rats received daily intra-bone marrow injections of TGF-beta 1 or vehicle for 4 days.
- Bone histomorphometry was performed on the femur metaphysis.
- Compared resorption parameters between TGF-beta 1-treated and vehicle-treated groups.
Main Results:
- Ovariectomy significantly increased resorption surface and osteoclast number.
- TGF-beta 1 treatment significantly reduced osteoclast surface and number compared to vehicle controls.
- Specific reduction observed with 0.2 ng of TGF-beta 1 (p < 0.05).
Conclusions:
- TGF-beta 1 demonstrates a potent inhibitory effect on bone resorption in vivo.
- TGF-beta 1 may represent a therapeutic target for managing bone loss associated with estrogen deficiency.